Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 9.9B | 10.1B | 8.6B | 7.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 473.4M | 296.5M | 289.3M | 255.1M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 10.2B | 9.3B | 10.0B | 6.8B |
| Tax provision | 2.9B | 2.0B | 3.1B | 1.3B |
| Net income | 7.3B | 7.4B | 6.9B | 5.6B |
| Basic EPS | — | 3.7 | 3.4 | 2.8 |
| Diluted EPS | — | 3.7 | 3.4 | 2.8 |
| Basic average shares | — | 2.0B | 2.0B | 2.0B |
| Diluted average shares | — | 2.0B | 2.0B | 2.0B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |